Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

被引：0
|
作者：
Javier Cortés
Hope S. Rugo
Ahmad Awada
Chris Twelves
Edith A. Perez
Seock–Ah Im
Patricia Gómez-Pardo
Lee S. Schwartzberg
Veronique Diéras
Denise A. Yardley
David A. Potter
Audrey Mailliez
Alvaro Moreno-Aspitia
Jin-Seok Ahn
Carol Zhao
Ute Hoch
Mary Tagliaferri
Alison L. Hannah
Joyce O’Shaughnessy
机构：
[1] Ramon y Cajal University Hospital,Medical Oncology Clinic
[2] Madrid,Department of Medicine, Masonic Cancer Center
[3] Spain and Vall d’Hebron Institute of Oncology,Department of Medicine, Samsung Medical Center
[4] University of California,undefined
[5] Jules Bordet Institute,undefined
[6] Leeds Institute of Cancer and Pathology and St James’s University Hospital,undefined
[7] Mayo Clinic,undefined
[8] Seoul National University Hospital,undefined
[9] Cancer Research Institute,undefined
[10] Seoul National University College of Medicine,undefined
[11] Vall d’Hebron Institute of Oncology,undefined
[12] The West Clinic,undefined
[13] Institut Curie,undefined
[14] Sarah Cannon Research Institute,undefined
[15] University of Minnesota,undefined
[16] Centre Oscar Lambret,undefined
[17] Sungkyunkwan University School of Medicine,undefined
[18] Nektar Therapeutics,undefined
[19] Consultant,undefined
[20] Texas Oncology-Baylor Charles A. Sammons Cancer Center/U.S. Oncology,undefined
来源：
Breast Cancer Research and Treatment | 2017年 / 166卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 328
页数：1
相关论文
共 50 条
  • [1] Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Cortes, Javier
    Rugo, Hope S.
    Awada, Ahmad
    Twelves, Chris
    Perez, Edith A.
    Im, Seock-Ah
    Gomez-Pardo, Patricia
    Schwartzberg, Lee S.
    Dieras, Veronique
    Yardley, Denise A.
    Potter, David A.
    Mailliez, Audrey
    Moreno-Aspitia, Alvaro
    Ahn, Jin-Seok
    Zhao, Carol
    Hoch, Ute
    Tagliaferri, Mary
    Hannah, Alison L.
    O'Shaughnessy, Joyce
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (02) : 329 - 341
  • [2] Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Javier Cortés
    Hope S. Rugo
    Ahmad Awada
    Chris Twelves
    Edith A. Perez
    Seock–Ah Im
    Patricia Gómez-Pardo
    Lee S. Schwartzberg
    Veronique Diéras
    Denise A. Yardley
    David A. Potter
    Audrey Mailliez
    Alvaro Moreno-Aspitia
    Jin-Seok Ahn
    Carol Zhao
    Ute Hoch
    Mary Tagliaferri
    Alison L. Hannah
    Joyce O’Shaughnessy
    Breast Cancer Research and Treatment, 2017, 165 : 329 - 341
  • [3] Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (vol 165, pg 329, 2017)
    Cortes, Javier
    Rugo, Hope S.
    Awada, Ahmad
    Twelves, Chris
    Perez, Edith A.
    Im, Seock-Ah
    Gomez-Pardo, Patricia
    Schwartzberg, Lee S.
    Dieras, Veronique
    Yardley, Denise A.
    Potter, David A.
    Mailliez, Audrey
    Moreno-Aspitia, Alvaro
    Ahn, Jin-Seok
    Zhao, Carol
    Hoch, Ute
    Tagliaferri, Mary
    Hannah, Alison L.
    O'Shaughnessy, Joyce
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 327 - 328
  • [4] Renal safety of ibandronate in patients with bone metastases from breast cancer:: phase III trial results
    Bell, R.
    Diel, I. J.
    Body, J.
    Bergstroem, B.
    EJC SUPPLEMENTS, 2004, 2 (03): : 132 - 132
  • [5] Survival in patients with brain metastases from breast cancer
    Eichler, April F.
    Kuter, Irene
    Ryan, Paula
    Schapira, Lidia
    Younger, Jerry
    Henson, John W.
    CANCER, 2008, 112 (11) : 2359 - 2367
  • [6] Phase II trial of patupilone in patients with brain metastases from breast cancer
    Peereboom, David M.
    Murphy, Conleth
    Ahluwalia, Manmeet S.
    Conlin, Alison
    Eichler, April
    Van Poznak, Catherine
    Baar, Joseph
    Elson, Paul
    Seidman, Andrew D.
    NEURO-ONCOLOGY, 2014, 16 (04) : 579 - 583
  • [7] Characteristics of patients with prolonged survival after breast cancer brain metastases (BCBM).
    Tomasevic, Zorica
    Kovac, Zeljko
    Tomasevic, Zoran
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Ibandronate is effective in preventing skeletal events in patients with bone metastases secondary to breast and colorectal cancer - Results from a randomized phase III trial
    Heras, P
    Karagiannis, S
    Kritikos, K
    Hatzopoulos, A
    Georgopoulou, P
    Mitsibounas, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P66 - P67
  • [9] Ibandronate is effective in preventing skeletal events in patients with bone metastases secondary to breast and colorectal cancer - Results from a randomized phase III trial
    Heras, P
    Karagiannis, S
    Kritikos, K
    Hatzopoulos, A
    Georgopoulou, PA
    CANCER TREATMENT REVIEWS, 2005, 31 : S51 - S51
  • [10] Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases Final Results From the Phase 3 ATTAIN Randomized Clinical Trial
    Tripathy, Debu
    Tolaney, Sara M.
    Seidman, Andrew D.
    Anders, Carey K.
    Ibrahim, Nuhad
    Rugo, Hope S.
    Twelves, Chris
    Dieras, Veronique
    Mueller, Volkmar
    Du, Yining
    Currie, Sue L.
    Hoch, Ute
    Tagliaferri, Mary
    Hannah, Alison L.
    Cortes, Javier
    JAMA ONCOLOGY, 2022, 8 (07) : 1047 - 1052
12345